Nektar Therapeutics reported $25.01M in Sales Revenues for its fourth fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Sales Change
Bluebird Bio BLUE:US $ 1.61M 21.07M
Dr.Reddys Laboratories DRRD:IN IR 53383M 4486M
Eisai 4523:JP Y 202972M 39514M
Immunogen IMGN:US $ 38.08M 10.09M
IONIS PHARMACEUT IONS:US $ 440M 306.91M
Ironwood Pharmaceuticals IRWD:US $ 97.53M 19.6M
Mirati Therapeutics MRTX:US $ 0.71M 0.41M
Nektar Therapeutics NKTR:US $ 25.01M 0.09M
Novartis NOVN:VX SF 13522M 155M
Teva Pharmaceutical TEVA:IT 4.1B 213M
Xencor XNCR:US $ 85.5M 68.52M